Research use only: difference between revisions
Diff·revision 36 → 37·00:47, 8 Feb 2026
Difference between revision 36 and revision 37 of Research use only. This revision changed no lines of source — the edit was a null or whitespace change.
| Revision 36 — 00:44, 16 Jan 2026 LabelLibby (talk) state that research-use-only labelling is a commercial category, not an approval 7,990 bytes ±0 | Revision 37 — 00:47, 8 Feb 2026 BiosimilarBoaz (talk) attribute the compounding statement to the pharmacy board that issued it 7,990 bytes ±0 | ||
|---|---|---|---|
| — | No change to the page source. | — |